ATC Group: A10BA02 Metformin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BA02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A10 Drugs used in diabetes
3 A10B Blood glucose lowering drugs, excl. insulins
4 A10BA Biguanides
5 A10BA02 Metformin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 2 g

Active ingredients in A10BA02

Active Ingredient

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

Related product monographs

Document Type Information Source  
 BROT Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 DIABETMIN Prolonged release tablet MPI, EU: SmPC Marketing Authorisation Holder
 DIAFORMIN Film-coated tablet MPI, EU: SmPC Pharmaceutical Benefits Scheme (AU)
 GLUCOPHAGE Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 GLUCOPHAGE Tablet / Extended-release tablet MPI, US: SPL/PLR FDA, National Drug Code (US)
 GLUMETZA Film coated tablet, extended release MPI, US: SPL/PLR FDA, National Drug Code (US)
 GLYFORMIN Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 METFORAL Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 SIOFOR Prolonged-release tablet MPI, EU: SmPC Health Products Regulatory Authority (IE)

United States medicines

Medicines classified under this ATC code globally

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.